| Product Name: | Xylometazoline Hydrochloride |
| Synonyms: | 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride |
| CAS No: | 1218-35-5 |
| Chemical Formula: | C16H24N2.ClH |
| Grade: | IP/BP/USP |
| Appearance: | White Solid powder |
| Molar Mass: | 280.8 g/mol |
| Solubility: | Freely soluble in water, ethanol, and methanol, but practically insoluble in ether and benzene. |
Description
Chemignition is a leading manufacturer and exporter of Xylometazoline Hydrochloride Active Pharmaceutical Ingredients (API) worldwide. The company follows strict Quality Management Systems (QMS) to ensure adherence to Good Manufacturing Practices (cGMPs). Chemignition’s commitment to quality and regulatory compliance guarantees that the Xylometazoline Hydrochloride produced maintains the highest purity and efficacy.
Manufacturers widely use Xylometazoline Hydrochloride as a nasal decongestant and vasoconstrictor, effectively relieving nasal congestion caused by colds, allergies, and sinusitis.
Chemignition utilizes advanced manufacturing techniques, including dissolution, charcoalization, filtration, leaching, extraction, crystallization, and purification processes, to ensure high-quality production of Active Pharmaceutical Ingredients (API) and specialty chemicals.
Pharmaceutical companies commonly use Xylometazoline Hydrochloride API in manufacturing products such as nasal sprays and eye drops.
The U.S. Food and Drug Administration (FDA) first approved Xylometazoline Hydrochloride in 1983. Manufacturers offer it in various formulations, particularly nasal sprays, and recognize its effectiveness in treating nasal congestion.
Storage Condition: Pack Xylometazoline Hydrochloride in a double polybag and store it in a tightly sealed HDPE container at a temperature between 15°C and 30°C.